肾素-血管紧张素系统的阻断及其对肾脏的保护作用

被引:7
作者
梁秀玲
邢燕
机构
[1] 新乡医学院第一附属医院儿科
关键词
肾素-血管紧张素系统; 血管紧张素转化酶抑制剂; 血管紧张素Ⅱ受体拮抗剂;
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
摘要
目的 探讨肾素 -血管紧张素系统 (RAS)在肾脏病中的作用及阻断RAS后对肾脏病的影响。方法 总结并分析近 1 0年相关文献。结果 血管紧张素Ⅱ在肾小球硬化中起重要作用 ,血管紧张素转化酶抑制剂 (ACEI)和血管紧张素Ⅱ受体 1拮抗剂 (AT1 RA)对肾脏有相同的保护作用。结论 ACEI和AT1 RA可阻断RAS对肾脏的损害
引用
收藏
页码:110 / 113
页数:4
相关论文
共 24 条
[1]  
Antiproteinuric effects of losartan in patients with chronic renal disease. Zoccali C,Valvo E,Russo D,et al. Nephrology Dialysis Transplantation . 1997
[2]  
Effects of losartan and captopril on endothenlin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Lariviere R,Lebel M,Kingma I,et al. American Journal of Hypertension . 1998
[3]  
Long-term comparison of losartan and enalapril in kidney function hypertensive type 2 diabetes with early nephropathy. Yves L,Andre B,Chantal G,et al. Kidney International . 2000
[4]  
Pathogenesis of glomerular injury in the Fawn-Hooded rats: effect of unilateral nephrectomy. Simons JL,Provoost AP,De Keijzer MH,et al. Journal of the American Society of Nephrology . 1993
[5]  
A randomized placebo- controlled double- blind parallel study of various doses of losartan potassium cmpared with enalapril maleate in patients with essential hypertension. Gradman AH,Arcuri KE,Goldberg AI,et al. Journal of Hypertension . 1995
[6]  
Renoprotective benefits of RASinhibition:from ACEI to angiotensinⅡantagonists. Taal MW,Brenner BM. Kidney International . 2000
[7]  
ACEI/ATRA therapy decreases protenuria by improving glomerolar permselecctivity in IgA nephritis. Woo KT,Lau YK,Wong KS,et al. Kidney International . 2000
[8]  
Angiotensin Ⅱ receptor blockade limits glomerular injury in rats with reduced renal mass. Lafayette RA,Mayer G,Park SK,et al. The Journal of Clinical Investigation . 1992
[9]  
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. Jerums G,Allen TJ,Campbell DJ,et al. American Journal of Kidney Diseases . 2001
[10]  
Additive antiproteinuric effect of converting enzyme inhinbitor and losartan in normotensive patients with IgA nephropathy. Russo D,Pisani A,Balleta MM,et al. American Journal of Kidney Diseases . 1999